Targeting the CD38-NAD⁺ axis alleviates antibody-driven cytopenia in autoimmune disorders without inducing broad immunosuppression
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Hui yuan Li, Lei Zhang
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417018489
